top of page
Your Partner in Research, Strategy, and Compliance
Triligent International is a research consulting organization (RCO) specializing in regulatory strategy, clinical operations, quality assurance, Investor and VC Support. Since 1993, we have guided sponsors, investors, and research teams through the complexities of drug and device development with rigor, precision, and trust.
Don Ashbrook, PhD
Founder & CEO
Don Ashbrook brings over 45 years of global experience in clinical research, regulatory affairs, biometrics, and quality assurance. His career spans the development, registration, and approval of pharmaceuticals, biologics, and medical devices, with particular expertise in clinical site and vendor oversight, auditing, and regulatory compliance across multiple therapeutic areas. He has trained sponsors, investigators, and regulatory agencies worldwide in Good Clinical Practice (GCP) and quality systems, and continues to guide organizations in strategic planning, project recovery, and quality-driven research execution.
Outside of his professional work, Don is an avid adventure photographer, capturing landscapes and moments from his global travels. Please enjoy photography can be viewed at donashbrook.smugmug.com.
“ I believe clinical research is about more than compliance—it’s about trust, collaboration, and making a meaningful difference for patients”.
Nina A. Cantafio
President & COO
Nina Cantafio is a clinical research leader with over 25 years of experience spanning academic, non-profit, industry, and consulting roles . She has directed clinical operations for investigator-initiated, industry-sponsored, and partner-sponsored trials across oncology, hepatology, infectious disease, and rare diseases, with expertise from protocol development through study closeout. At Triligent, Nina drives the organization’s strategic vision, overseeing clinical trial management, regulatory compliance, and data-driven solutions for biopharma, medical device, academic, and healthcare partners. She is recognized for her ability to build collaborations, recover at-risk projects, and guide research teams through complex regulatory landscapes. Committed to mentoring the next generation of clinical researchers, she lectures regularly on careers in science and clinical research. Beyond her professional work, she is a dedicated patient advocate and active supporter of community health and education initiatives.
“ I joined Triligent over 20 years ago because of what sets us apart - our commitment to true partnership with sponsors, investigators, and research teams to advance science that makes a real difference in patients’ lives”.
bottom of page